How Dobbs v. Jackson is affecting vaccine innovation
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger…
Nkarta, Novartis announce positive data in cancer treatment trials
Positive results in trials of cancer treatments were announced by the biotech firms…
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing
“The pandemic has exposed our country’s dependence on other countries for essential prescription…
We can beat world hunger with systemic reforms and biotech, says FAO
According to a recent assessment from the U.N. Food and Agriculture Organization (FAO),…
What to know during Crohn’s and Colitis Awareness Week
Today marks the last day of Crohn’s and Colitis Awareness Week, an opportunity…
55% of FDA-approved drugs were developed by U.S. small biotechs, says study
The U.S. was solely responsible for 61% of medicines approved by the U.S….
EDITORS’ CHOICE
How Dobbs v. Jackson is affecting vaccine innovation
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk…
Read more
Latest News
How Dobbs v. Jackson is affecting vaccine innovation
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk…
Nkarta, Novartis announce positive data in cancer treatment trials
Positive results in trials of cancer treatments were announced by the biotech firms Nkarta and Novartis this week. Nkarta trial…
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at…
We can beat world hunger with systemic reforms and biotech, says FAO
According to a recent assessment from the U.N. Food and Agriculture Organization (FAO), systemic reforms – as well as advancements…
What to know during Crohn’s and Colitis Awareness Week
Today marks the last day of Crohn’s and Colitis Awareness Week, an opportunity to highlight the plight of between 1.6…
HEALTH
COVID-19 forced us to reimagine pharma supply chains – and that’s a good thing.
BIO’s Chief Policy Officer John Murphy joined a panel hosted by The Hill to discuss how the pandemic affected drug supply chains and the opportunity to improve them going forward.
AGRICULTURE
CLIMATE CHANGE
How biotech is making it easier to put bread on the table
Wheat harvests will face pressure from climate change, scientists say. But biotechnology is working on ways to make it easier…
Read more
FEDERAL POLICY
STATE POLICY
How Dobbs v. Jackson is affecting vaccine innovation
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk…
Read more
INTERNATIONAL
BIO’s VIEW
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at…
Read more
